Avenue Therapeutics raises ~$550k in private placement at $0.717/share from Fortress and Rosenwald

AVENUE THERAPEUTICS, INC.

Issued 767,085 shares at $0.717/share (Nasdaq closing bid on Sept 7, 2023) to Fortress Biotech and Dr. Lindsay Rosenwald.
No underwriting or placement agent fees incurred; gross proceeds ~$550,000.
Proceeds intended for working capital and general corporate purposes.
Registration rights agreement obligates filing of resale registration statement by September 8, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.